This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Boehringer Ingelheim GmbH
Drug Names(s): BILN 2061 h
Description: BILN 2061 is a novel oral HCV serine protease inhibitor.
BILN 2061 News
Pink Sheet Office for Human Research Trials
Additional information available to subscribers only: